MOTCO’s Genmab GMAB Stock Holding History

MOTCO’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$604	Buy	+22	New	+$585	﹤0.01%	645
2023 Q3	–	Sell	-13	Closed	-$494	–	886
2023 Q2	$494	Buy	+13	New	+$518	﹤0.01%	862

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

MOTCO's GMAB Position: Q2 2026 in Review

MOTCO opened a new position in Genmab (GMAB) in Q2 2026: 22 shares worth $604. The stake represents ﹤0.01% of the portfolio and ranks #645 among its holdings. This is a return to the name: MOTCO previously reported a position in GMAB as recently as Q2 2023.

MOTCO first reported a position in GMAB in Q2 2023 and has held it in 2 quarters since. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

MOTCO held 22 shares of Genmab worth $604 as of Q2 2026.
Genmab was a new MOTCO position in Q2 2026.
Genmab made up ﹤0.01% of MOTCO's portfolio in Q2 2026, its #645 holding.
MOTCO first reported a position in Genmab in Q2 2023 and has held it in 2 quarters since.
291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on MOTCO's 13F filing for Q2 2026, filed 31 Jul 2026.